|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,351.60 INR | +0.17% |
|
-0.48% | -10.23% |
| Capitalization | 187B 2.03B 1.76B 1.59B 1.52B 2.76B 2.86B 18.93B 7.52B 89.46B 7.61B 7.45B 323B | P/E ratio 2026 * |
37.6x | P/E ratio 2027 * | 27.2x |
|---|---|---|---|---|---|
| Enterprise value | 207B 2.24B 1.95B 1.76B 1.68B 3.06B 3.16B 20.95B 8.32B 99.01B 8.42B 8.24B 357B | EV / Sales 2026 * |
6.48x | EV / Sales 2027 * | 5.34x |
| Free-Float |
27.81% | Yield 2026 * |
0.38% | Yield 2027 * | 0.57% |
Last Transcript: Eris Lifesciences Limited
| 1 day | +0.17% | ||
| 1 week | -0.48% | ||
| Current month | -0.49% | ||
| 1 month | -8.00% | ||
| 3 months | -15.03% | ||
| 6 months | -20.46% | ||
| Current year | -10.23% |
| 1 week | 1,300.6 | 1,369.2 | |
| 1 month | 1,300.6 | 1,511 | |
| Current year | 1,300.6 | 1,563 | |
| 1 year | 1,097.2 | 1,910 | |
| 3 years | 551.3 | 1,910 | |
| 5 years | 551.3 | 1,910 | |
| 10 years | 321 | 1,910 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 26/01/2007 | |
Sachin Shah
DFI | Director of Finance/CFO | 46 | 27/09/2016 |
Vijay S. Joshi
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 52 | 26/01/2007 | |
| Director/Board Member | 54 | 26/01/2007 | |
Prashant Gupta
BRD | Director/Board Member | 46 | 29/04/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.17% | -0.48% | +6.59% | +121.01% | 2.03B | ||
| -2.26% | -2.62% | +18.59% | +210.22% | 893B | ||
| -0.39% | -1.33% | +45.93% | +59.65% | 586B | ||
| -1.01% | -4.58% | +5.52% | +50.54% | 403B | ||
| -0.62% | -11.32% | +7.32% | +20.69% | 338B | ||
| -0.83% | -4.80% | +25.12% | +34.27% | 301B | ||
| -0.33% | -5.36% | +26.27% | +61.94% | 297B | ||
| -0.26% | -3.63% | +22.36% | +7.63% | 287B | ||
| -2.61% | -3.03% | +15.33% | +61.40% | 204B | ||
| -0.54% | -2.03% | +26.90% | +82.65% | 181B | ||
| Average | -0.67% | -2.79% | +19.99% | +71.00% | 349.12B | |
| Weighted average by Cap. | -0.90% | -2.60% | +22.34% | +88.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 32B 347M 301M 272M 260M 472M 489M 3.24B 1.28B 15.29B 1.3B 1.27B 55.19B | 37.29B 404M 350M 317M 302M 550M 569M 3.77B 1.5B 17.82B 1.52B 1.48B 64.31B |
| Net income | 4.83B 52.35M 45.41M 41.06M 39.21M 71.31M 73.81M 489M 194M 2.31B 196M 192M 8.34B | 6.85B 74.15M 64.32M 58.16M 55.53M 101M 105M 692M 275M 3.27B 278M 272M 11.81B |
| Net Debt | 19.99B 217M 188M 170M 162M 295M 305M 2.02B 803M 9.55B 812M 795M 34.48B | 11.86B 128M 111M 101M 96.17M 175M 181M 1.2B 476M 5.67B 482M 472M 20.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/03/26 | 1,351.60 ₹ | +0.17% | 40,764 |
| 11/03/26 | 1,349.30 ₹ | -0.13% | 35,750 |
| 10/03/26 | 1,351.10 ₹ | +1.71% | 100,690 |
| 09/03/26 | 1,328.40 ₹ | -2.37% | 47,652 |
| 06/03/26 | 1,360.70 ₹ | -0.69% | 19,895 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERIS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















